Patents Assigned to Theranostech, Inc.
  • Patent number: 7521176
    Abstract: Methods in accordance with the present invention involve novel measurements of the disease status of hosts infected with the human immunodeficiency virus. In particular, the present invention relates to a measurements of the numbers in a sample volume of (a) productively HIV-infected cells and (b) cells capable of being infected by HIV, e.g., cells expressing CD4, CCR5, and/or CXCR4. These two values can be represented as a single ratio, e.g., number of productively infected cells/number of cells capable of being infected by HIV, and can be utilized as an indicator of disease status, such as disease progression, viral replication, etc.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: April 21, 2009
    Assignee: Theranostech, Inc.
    Inventors: Robert A Hallowitz, John Krowka, Shawn Matlock